The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mirap DisTab 45 mg Orodispersible Tablets

Rowex LtdPA0711/094/003

Main Information

Trade NameMirap DisTab 45 mg Orodispersible Tablets
Active SubstancesMirtazapine
Dosage FormOrodispersible tablet
Licence HolderRowex Ltd
Licence NumberPA0711/094/003

Group Information

ATC CodeN06AX Other antidepressants
N06AX11 mirtazapine


License statusAuthorised
Licence Issued03/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0061-110-015
Interchangeable List DocumentPDF of Interchangeable List
« Back